Xeris Pharmaceuticals Inc (XERS) — Long-term Investment Intensity
Xeris Pharmaceuticals Inc (XERS) has a Long-term Investment Intensity of 1.1% as of June 2020. Long-term investments of $1.79 Million represent 1.1% of total assets of $165.81 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See XERS working capital ratio to evaluate short-term liquidity relative to the company's equity base.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Xeris Pharmaceuticals Inc Long-term Investment Intensity (2019–2019)
This chart shows how Xeris Pharmaceuticals Inc's Long-term Investment Intensity has evolved across 1 annual periods from 2019 to 2019. As of June 2020, the intensity stands at 1.1%, reflecting long-term investments of $1.79 Million against total assets of $165.81 Million USD. See XERS days of operational coverage to measure how many days the company can operate on defensive assets alone.
Annual Long-term Investment Intensity for Xeris Pharmaceuticals Inc (2019–2019)
The table below presents the year-by-year Long-term Investment Intensity for Xeris Pharmaceuticals Inc from 2019 to 2019, covering 1 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see how large is Xeris Pharmaceuticals Inc's balance sheet.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2019 | 12.1% | $13.23 Million | $108.99 Million | — |